Literature DB >> 1879362

The expression of NG2 proteoglycan in the developing rat limb.

A Nishiyama1, K J Dahlin, W B Stallcup.   

Abstract

NG2 is a chondroitin sulfate proteoglycan previously found to be expressed by glial progenitor cells of the O2A lineage. We have examined the expression of NG2 in the developing rat limb by immunohistochemistry and northern blot analysis. Staining of embryonic day 14 (E14) rat limb bud sections with polyclonal and monoclonal anti-NG2 antibodies reveals reactivity in the precartilaginous mesenchymal condensation. The staining intensity increases with the differentiation of chondrocytes until E16. NG2 staining is not detected in the mature hypertrophic chondrocytes of E17 and postnatal day 3 (P3) limbs even after treatment of the sections with hyaluronidase or collagenase. Immuno-precipitations with anti-NG2 antibody using 125I-labeled limb cells in culture showed a 400 to 800 x 10(3) Mr proteoglycan species with a core protein size of 300 x 10(3) Mr, comparable to NG2 from O2A cells and neural cell lines. Northern blot analysis reveals the expression of an 8.9 kb mRNA in E16 limbs and at a lower level in P1 cartilage. The northern blot analyses also show that NG2 is distinct from the large aggregating proteoglycan of the cartilage. Our results indicate that in the developing limb cartilage, as in the differentiating oligodendrocytes, NG2 is present on immature cells in the process of differentiating, but its expression is downregulated as terminal differentiation of chondrocytes takes place.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879362     DOI: 10.1242/dev.111.4.933

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  20 in total

1.  The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2.

Authors:  D S Barritt; M T Pearn; A H Zisch; S S Lee; R T Javier; E B Pasquale; W B Stallcup
Journal:  J Cell Biochem       Date:  2000-08-02       Impact factor: 4.429

2.  NG2 proteoglycan expression in mouse skin: altered postnatal skin development in the NG2 null mouse.

Authors:  Kuniko Kadoya; Jun-Ichi Fukushi; Yoshihiro Matsumoto; Yu Yamaguchi; William B Stallcup
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

3.  Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface.

Authors:  A Nishiyama; W B Stallcup
Journal:  Mol Biol Cell       Date:  1993-11       Impact factor: 4.138

Review 4.  Molecular cloning and analysis of the protein modules of aggrecans.

Authors:  W B Upholt; L Chandrasekaran; M L Tanzer
Journal:  Experientia       Date:  1993-05-15

5.  Differences in tendon graft healing between the intra-articular and extra-articular ends of a bone tunnel.

Authors:  Asheesh Bedi; Sumito Kawamura; Liang Ying; Scott A Rodeo
Journal:  HSS J       Date:  2008-12-04

6.  Molecular heterogeneity of chondroitin sulphate in the early developing chick wing bud.

Authors:  M Fernandez-Teran; M Bayliss; C W Archer
Journal:  Anat Embryol (Berl)       Date:  1993-08

Review 7.  A role for the NG2 proteoglycan in glioma progression.

Authors:  William B Stallcup; Feng-Ju Huang
Journal:  Cell Adh Migr       Date:  2008-07-13       Impact factor: 3.405

8.  Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis.

Authors:  A Nishiyama; X H Lin; W B Stallcup
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

9.  NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.

Authors:  Zhi-Gang She; Yunchao Chang; Hong-Bo Pang; Wenlong Han; Hou-Zao Chen; Jeffrey W Smith; William B Stallcup
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-05       Impact factor: 8.311

10.  Global comparative transcriptome analysis of cartilage formation in vivo.

Authors:  Trevor L Cameron; Daniele Belluoccio; Peter G Farlie; Bent Brachvogel; John F Bateman
Journal:  BMC Dev Biol       Date:  2009-03-10       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.